AN2 Therapeutics
ANTX
ANTX
37 hedge funds and large institutions have $320M invested in AN2 Therapeutics in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.66% more ownership
Funds ownership: 60.43% → 67.09% (+6.7%)
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$28.6M | |
| 2 | +$22.3M | |
| 3 | +$22.3M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$14.6M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$11.5M |
Top Sellers
| 1 | -$1.33M | |
| 2 | -$779K | |
| 3 | -$634K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$574K |
| 5 |
Barclays
London,
United Kingdom
|
-$385K |